Ehrlichia and Anaplasma Species by PCR

Casandra

Casandra Test Code AR72416Version 1 (DRAFT)

Performing Lab

Lab ARUP LaboratoriesLab Test ID 2007862CPT Codes 87468, 87484, 87798

Ehrlichia and Anaplasma Species by PCR

Also known as: EHR ANAPCR

Clinical Use

Order Test

Use

This test is primarily used for the diagnosis of possible tick-borne diseases such as Anaplasmosis or Ehrlichiosis during the acute phase of the disease. PCR provides a rapid means for the qualitative detection and speciation of DNA from Anaplasma phagocytophilum, Ehrlichia chaffeensis, Ehrlichia ewingii/E. canis, and E. muris-like pathogens, aiding in timely diagnosis and patient management. However, it should be noted that E. ewingii and E. canis cannot be differentiated by this test.

Special Instructions

This test is approved for use in New York state. It should be ordered during the acute phase of suspected infection for optimal results. Be aware that serum, plasma, and heparinized specimens are unacceptable for this test.

Limitations

A negative result does not exclude the presence of PCR inhibitors in the patient specimen or the presence of target DNA below the detectable level of the assay. Additionally, the test cannot differentiate between E. ewingii and E. canis if detected. As this is a Laboratory Developed Test, it has not been cleared or approved by the US Food and Drug Administration, but it is performed in a CLIA certified laboratory for clinical purposes.

Test Details

New York Approved